Purpose: This study aimed to explore the association of rs857148 A>C as 3ʹUTR variants with blood pressure, HbA1c profile, and lipid profiles as cardiometabolic parameters among patients with T2DM receiving metformin.
Patients and Methods: This cross-sectional analytic research was conducted with 114 consecutively selected patients with T2DM. Polymerase chain reaction-restriction fragment length polymorphism was conducted to determine rs857148 . A total of 108 patients fulfilled inclusion and exclusion criteria.
Results: Genotype distribution agreed with the Hardy Weinberg Equation for Equilibrium (p > 0.05) but wildtype allele was found as the minor allele. Subjects with CC genotype and C allele had enhanced HbA1c levels (OR=7.12; 95% CI=1.05– 48.26; p =0.04; OR=1.66; 95% CI=1.06– 2.60; p =0.03, respectively). It was confirmed by dominant model whereas subjects with AA tended to have reduced HbA1c compared to AC+CC genotype (OR=0.15; 95% CI=0.02– 0.97; p =0.047). AC genotype had significant correlation to total cholesterol (OR=1.05; 95% CI=1.01– 1.10; p =0.03) compared to AA genotype.
Conclusion: We conclude that polymorphism of rs87148 , specifically CC genotype and C allele, has a significant association with HbA1c and total cholesterol after considering oral hypoglycemia agent dose, age, gender, and combination therapy, compared to AA genotype. Future studies that involve a larger sample population and more rigorous selection criteria are required.
Keywords: PRKAA2 , rs857148, 3ʹUTR, cardiometabolic, type 2 diabetes mellitus